• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

柏拉木提取物与顺铂联合作用通过抑制 AKT/mTOR 和 MAPK 信号通路和诱导细胞凋亡来对抗黑素瘤细胞。

Juniperus indica Bertol. extract synergized with cisplatin against melanoma cells via the suppression of AKT/mTOR and MAPK signaling and induction of cell apoptosis.

机构信息

Institute of Medicine, Chung Shan Medical University, Taichung, 40201, Taiwan, ROC.

Department of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung, 40201, Taiwan, ROC.

出版信息

Int J Med Sci. 2021 Jan 1;18(1):157-168. doi: 10.7150/ijms.49423. eCollection 2021.

DOI:10.7150/ijms.49423
PMID:33390784
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7738970/
Abstract

Bertol. is an herbal plant that belongs to the genus , which is commonly used in traditional medicine to refresh the mind and for diuretic use. However, few studies have reported the function of Bertol. Hence, this study aimed to investigate the anti-tumor and synergistic potential of Bertol. extract (JIB extract) for melanoma cells. Our results indicated the anti-melanoma activity of JIB extract. JIB extract induced cell cycle arrest at the G/G phase and decreased cyclin and cdk protein expressions. In addition, AKT/mTOR signaling and MAPK signaling were inhibited by JIB extract to suppress melanoma cell growth and proliferation. Additionally, JIB extract induced B16/F10 cell apoptosis via the caspase cascade. According to the JIB extract's anti-melanoma capacity, to assess the synergistic effects of cisplatin and JIB extract. The results demonstrated that JIB extract combined with cisplatin enhanced the inhibition of cell growth, proliferation, and survival through the obstruction of cell cycle progression and AKT/mTOR and MAPK signaling as well as the induction of cell apoptosis. Collectively, our results indicate that JIB extract showed anti-tumor effects and synergized with cisplatin against B16/F10 cells, indicating the possibility of JIB extract to be developed as adjuvant therapy for melanoma.

摘要

博尔托。是一种属于 的草药植物,在传统医学中常用于提神和利尿。然而,很少有研究报道 博尔托。的功能。因此,本研究旨在探讨 博尔托。提取物(JIB 提取物)对黑素瘤细胞的抗肿瘤和协同作用。我们的结果表明 JIB 提取物具有抗黑色素瘤活性。JIB 提取物诱导细胞周期停滞在 G/G 期,并降低细胞周期蛋白和 CDK 蛋白的表达。此外,JIB 提取物通过抑制 AKT/mTOR 信号和 MAPK 信号通路来抑制黑素瘤细胞的生长和增殖。此外,JIB 提取物通过半胱天冬酶级联诱导 B16/F10 细胞凋亡。根据 JIB 提取物的抗黑色素瘤能力,评估顺铂和 JIB 提取物的协同作用。结果表明,JIB 提取物与顺铂联合使用通过阻止细胞周期进程和 AKT/mTOR 和 MAPK 信号通路以及诱导细胞凋亡来增强对细胞生长、增殖和存活的抑制作用。总之,我们的结果表明,JIB 提取物表现出抗肿瘤作用,并与顺铂协同作用于 B16/F10 细胞,表明 JIB 提取物有可能开发为黑色素瘤的辅助治疗药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/985a/7738970/984d2d16648d/ijmsv18p0157g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/985a/7738970/41abb0e91e77/ijmsv18p0157g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/985a/7738970/c54bf447440a/ijmsv18p0157g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/985a/7738970/bed9ff5c8c37/ijmsv18p0157g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/985a/7738970/a45d5a2936f9/ijmsv18p0157g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/985a/7738970/984d2d16648d/ijmsv18p0157g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/985a/7738970/41abb0e91e77/ijmsv18p0157g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/985a/7738970/c54bf447440a/ijmsv18p0157g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/985a/7738970/bed9ff5c8c37/ijmsv18p0157g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/985a/7738970/a45d5a2936f9/ijmsv18p0157g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/985a/7738970/984d2d16648d/ijmsv18p0157g005.jpg

相似文献

1
Juniperus indica Bertol. extract synergized with cisplatin against melanoma cells via the suppression of AKT/mTOR and MAPK signaling and induction of cell apoptosis.柏拉木提取物与顺铂联合作用通过抑制 AKT/mTOR 和 MAPK 信号通路和诱导细胞凋亡来对抗黑素瘤细胞。
Int J Med Sci. 2021 Jan 1;18(1):157-168. doi: 10.7150/ijms.49423. eCollection 2021.
2
Extract of Synergizes with Cisplatin to Inhibit Oral Cancer Cell Growth via Repression of Cell Cycle Progression and Activation of the Caspase Cascade.姜黄素通过抑制细胞周期进程和激活半胱天冬酶级联反应协同顺铂抑制口腔癌细胞生长。
Molecules. 2020 Jun 13;25(12):2746. doi: 10.3390/molecules25122746.
3
Suppression of oral cancer by induction of cell cycle arrest and apoptosis using Juniperus communis extract.采用杜松提取物诱导细胞周期停滞和凋亡抑制口腔癌。
Biosci Rep. 2020 Sep 30;40(9). doi: 10.1042/BSR20202083.
4
NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.NVP-BEZ235,一种新型的双重 PI3K-mTOR 抑制剂,在人神经胶质瘤细胞中显示出抗神经胶质瘤活性,并降低替莫唑胺的化疗耐药性。
Cancer Lett. 2015 Oct 10;367(1):58-68. doi: 10.1016/j.canlet.2015.07.007. Epub 2015 Jul 15.
5
SKLB-M8 induces apoptosis through the AKT/mTOR signaling pathway in melanoma models and inhibits angiogenesis with decrease of ERK1/2 phosphorylation.在黑色素瘤模型中,SKLB-M8通过AKT/mTOR信号通路诱导细胞凋亡,并通过降低ERK1/2磷酸化来抑制血管生成。
J Pharmacol Sci. 2014;126(3):198-207. doi: 10.1254/jphs.14077fp. Epub 2014 Oct 21.
6
Vitamin D and its low calcemic analogs modulate the anticancer properties of cisplatin and dacarbazine in the human melanoma A375 cell line.维生素 D 及其低钙类似物可调节顺铂和达卡巴嗪在人黑色素瘤 A375 细胞系中的抗癌特性。
Int J Oncol. 2019 Apr;54(4):1481-1495. doi: 10.3892/ijo.2019.4725. Epub 2019 Feb 25.
7
Synergistic targeted inhibition of MEK and dual PI3K/mTOR diminishes viability and inhibits tumor growth of canine melanoma underscoring its utility as a preclinical model for human mucosal melanoma.MEK与双PI3K/mTOR的协同靶向抑制降低了犬黑色素瘤的活力并抑制其肿瘤生长,突出了其作为人类黏膜黑色素瘤临床前模型的效用。
Pigment Cell Melanoma Res. 2016 Nov;29(6):643-655. doi: 10.1111/pcmr.12512. Epub 2016 Sep 22.
8
Inhibition of PI3K-AKT-mTOR signaling sensitizes melanoma cells to cisplatin and temozolomide.抑制PI3K-AKT-mTOR信号传导可使黑色素瘤细胞对顺铂和替莫唑胺敏感。
J Invest Dermatol. 2009 Jun;129(6):1500-15. doi: 10.1038/jid.2008.379. Epub 2008 Dec 11.
9
RY-2f, an isoflavone analog, overcomes cisplatin resistance to inhibit ovarian tumorigenesis via targeting the PI3K/AKT/mTOR signaling pathway.异黄酮类似物RY-2f通过靶向PI3K/AKT/mTOR信号通路克服顺铂耐药性,从而抑制卵巢肿瘤发生。
Oncotarget. 2015 Sep 22;6(28):25281-94. doi: 10.18632/oncotarget.4634.
10
Extract of Thunb. enhances the inhibitory effect of 5-fluorouracil on gastric cancer cells through the AKT-mTOR pathway.雷公藤提取物通过 AKT-mTOR 通路增强 5-氟尿嘧啶对胃癌细胞的抑制作用。
World J Gastroenterol. 2019 Apr 21;25(15):1854-1864. doi: 10.3748/wjg.v25.i15.1854.

引用本文的文献

1
Aqueous Extracts of Sensitize Hepatocellular Carcinoma Cells to Cisplatin through BRCA1 Inhibition.水提取物通过抑制 BRCA1 使肝癌细胞对顺铂敏感。
Int J Mol Sci. 2024 Aug 1;25(15):8424. doi: 10.3390/ijms25158424.
2
Moench: Chemical Composition, Herbicidal and Insecticidal Activities of Its Essential Oil and of Its Main Component, Sabinene.蒙奇:其精油及其主要成分柠檬烯的化学成分、除草和杀虫活性。
Molecules. 2022 Dec 1;27(23):8408. doi: 10.3390/molecules27238408.

本文引用的文献

1
Vemurafenib in Patients With Relapsed Refractory Multiple Myeloma Harboring Mutations: A Cohort of the Histology-Independent VE-BASKET Study.维莫非尼治疗携带 突变的复发难治性多发性骨髓瘤患者:组织学独立的 VE-BASKET 研究队列
JCO Precis Oncol. 2018 Aug 31;2. doi: 10.1200/PO.18.00070. eCollection 2018.
2
Inhibition of p38/MK2 Signaling Prevents Vascular Invasion of Melanoma.p38/MK2 信号抑制可防止黑色素瘤的血管侵犯。
J Invest Dermatol. 2020 Apr;140(4):878-890.e5. doi: 10.1016/j.jid.2019.08.451. Epub 2019 Oct 14.
3
Long-Term Vemurafenib Exposure Induced Alterations of Cell Phenotypes in Melanoma: Increased Cell Migration and Its Association with EGFR Expression.
长期维莫非尼暴露诱导黑色素瘤细胞表型改变:细胞迁移增加及其与 EGFR 表达的关系。
Int J Mol Sci. 2019 Sep 11;20(18):4484. doi: 10.3390/ijms20184484.
4
Synergistic Effects of Plant Derivatives and Conventional Chemotherapeutic Agents: An Update on the Cancer Perspective.植物衍生物与传统化疗药物的协同作用:癌症视角的最新研究进展。
Medicina (Kaunas). 2019 Apr 17;55(4):110. doi: 10.3390/medicina55040110.
5
Vemurafenib and cobimetinib combination therapy for BRAFV600E-mutated melanoma favors posterior reversible encephalopathy syndrome.维莫非尼与考比替尼联合治疗BRAFV600E突变型黑色素瘤易引发后部可逆性脑病综合征。
Ann Oncol. 2019 Jun 1;30(6):1014-1016. doi: 10.1093/annonc/mdz114.
6
Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001.KEYNOTE-001 研究中接受派姆单抗治疗的晚期黑色素瘤患者的 5 年生存结果。
Ann Oncol. 2019 Apr 1;30(4):582-588. doi: 10.1093/annonc/mdz011.
7
Synergistic effects of vemurafenib and fingolimod (FTY720) in vemurafenib‑resistant melanoma cell lines.维莫非尼耐药黑色素瘤细胞系中维莫非尼与芬戈莫德(FTY720)的协同作用。
Mol Med Rep. 2018 Dec;18(6):5151-5158. doi: 10.3892/mmr.2018.9537. Epub 2018 Oct 8.
8
The role for chemotherapy in the modern management of melanoma.化疗在黑色素瘤现代治疗中的作用。
Melanoma Manag. 2017 May;4(2):125-136. doi: 10.2217/mmt-2017-0003. Epub 2017 May 19.
9
Aberrations and clinical significance of BRAF in malignant melanoma: A series of 60 cases in Chinese Uyghur.BRAF在恶性黑色素瘤中的畸变及其临床意义:60例中国维吾尔族病例系列研究
Medicine (Baltimore). 2018 Jan;97(1):e9509. doi: 10.1097/MD.0000000000009509.
10
NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab ± everolimus for metastatic melanoma.NCCTG N0879(Alliance):卡铂、紫杉醇和贝伐珠单抗联合或不联合依维莫司治疗转移性黑色素瘤的随机 2 期合作组试验。
Cancer. 2018 Feb 1;124(3):537-545. doi: 10.1002/cncr.31072. Epub 2017 Oct 17.